| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S9097 |
Home visit for wound care |
111,089 |
13,148 |
$8.69M |
| 97602 |
|
72,204 |
7,370 |
$6.29M |
| J9035 |
Injection, bevacizumab, 10 mg |
1,317 |
655 |
$5.44M |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
842 |
507 |
$3.67M |
| T1030 |
Nursing care, in the home, by registered nurse, per diem |
23,089 |
5,504 |
$2.54M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
20,024 |
2,102 |
$2.24M |
| J9299 |
Injection, nivolumab, 1 mg |
628 |
281 |
$2.24M |
| J9306 |
Injection, pertuzumab, 1 mg |
417 |
263 |
$1.78M |
| J9271 |
Injection, pembrolizumab, 1 mg |
266 |
206 |
$1.13M |
| J9312 |
Injection, rituximab, 10 mg |
276 |
162 |
$1.10M |
| E2402 |
Negative pressure wound therapy electrical pump, stationary or portable |
1,804 |
665 |
$1.06M |
| S9494 |
Home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with home infusion codes for hourly dosing schedules s9497-s9504) |
10,692 |
3,550 |
$1.03M |
| J1335 |
Injection, ertapenem sodium, 500 mg |
1,648 |
798 |
$820K |
| S9131 |
Physical therapy; in the home, per diem |
6,438 |
774 |
$723K |
| J9395 |
Injection, fulvestrant, 25 mg |
311 |
215 |
$482K |
| T1001 |
Nursing assessment / evaluation |
6,153 |
5,071 |
$426K |
| J9310 |
Injection, rituximab, 100 mg |
77 |
25 |
$380K |
| J0878 |
Injection, daptomycin, 1 mg |
564 |
131 |
$302K |
| J0897 |
Injection, denosumab, 1 mg |
114 |
104 |
$203K |
| J9070 |
Cyclophosphamide, 100 mg |
478 |
282 |
$197K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
1,298 |
534 |
$78K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
738 |
341 |
$70K |
| S9129 |
Occupational therapy, in the home, per diem |
602 |
30 |
$69K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
652 |
330 |
$67K |
| J3489 |
Injection, zoledronic acid, 1 mg |
686 |
527 |
$59K |
| M0223 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
463 |
362 |
$57K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,058 |
572 |
$48K |
| J9171 |
Injection, docetaxel, 1 mg |
454 |
259 |
$47K |
| G0157 |
Services performed by a qualified physical therapist assistant in the home health or hospice setting, each 15 minutes |
444 |
107 |
$33K |
| 99600 |
Unlisted home visit service or procedure |
480 |
359 |
$31K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
242 |
162 |
$28K |
| J9267 |
Injection, paclitaxel, 1 mg |
932 |
393 |
$26K |
| J9045 |
Injection, carboplatin, 50 mg |
778 |
415 |
$23K |
| J9190 |
Injection, fluorouracil, 500 mg |
1,841 |
610 |
$21K |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
197 |
94 |
$18K |
| J2185 |
Injection, meropenem, 100 mg |
64 |
28 |
$13K |
| S9379 |
Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
289 |
113 |
$11K |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
423 |
252 |
$10K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
64 |
41 |
$9K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
68 |
40 |
$8K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,143 |
1,901 |
$6K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
39 |
34 |
$4K |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
91 |
41 |
$4K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
53 |
49 |
$4K |
| J9206 |
Injection, irinotecan, 20 mg |
78 |
42 |
$3K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
17 |
15 |
$1K |
| 97597 |
|
4,508 |
577 |
$1K |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
22 |
12 |
$452.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
320 |
262 |
$449.71 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
299 |
243 |
$323.39 |
| S0028 |
Injection, famotidine, 20 mg |
23 |
16 |
$16.19 |
| 99341 |
|
13 |
13 |
$0.00 |